🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rifaquat Rahman

Brigham and Women's Hospital

ORCID: 0000-0002-9443-1797

Also affiliated with Harvard University, Dana-Farber Cancer Institute, Mater Private Hospital, Dana-Farber Brigham Cancer Center

MedicineMathematicsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.369Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials

Database(2021)10.1093/database/baab037

Top 49%

0.369DataRank

Top 49%4 citations

Robert Redd, Alyssa M. Vanderbeek, Rifaquat Rahman, Bill Louv, Jon McDunn +5 more

Papers

Driven by 13 papers — median percentile 51. Top paper: “The design and evaluation of hybrid controlled trials that leverage external data and randomization”.

The design and evaluation of hybrid controlled trials that leverage external data and randomization

Nature Communications(2022)10.1038/s41467-022-33192-1

N/A

1.0DataRank · unranked

34 citations

Sean Khozin, Bill Louv, Jacob Sands, Patrick Y. Wen, Rifaquat Rahman +4 more

KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials

Database(2021)10.1093/database/baab037

Top 49%

0.369DataRank

Top 49%4 citations

Robert Redd, Alyssa M. Vanderbeek, Rifaquat Rahman, Bill Louv, Jon McDunn +5 more

Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making

Neuro-Oncology(2021)10.1093/neuonc/noab282

N/A

0DataRank · unranked

30 citations

Gilbert C Youssef, Mehdi Touat, J. Bryan Iorgulescu, Sydney Whorral, Marie Allen +17 more

DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis

Journal of Neuro-Oncology(2022)10.1007/s11060-022-03994-w

N/A

0DataRank · unranked

5 citations

Helen H. Shang, Chantel Cacciotti, Emily Everdell, Ayal A. Aizer, Rifaquat Rahman +11 more

Patient specific distortion detection and mitigation in MR images used for stereotactic radiosurgery

Physics in Medicine and Biology(2022)10.1088/1361-6560/ac508e

N/A

0DataRank · unranked

4 citations

Xin Miao, Evangelia Kaza, Manuel Schneider, Martin Requardt, Thorsten Feiweier +7 more

Trends in location of death for individuals with primary brain tumors in the United States

Neuro-Oncology(2022)10.1093/neuonc/noac075

N/A

0DataRank · unranked

3 citations

Edward Christopher Dee, Urvish Jain, Ayal A. Aizer, Wenya Linda Bi, Daphne A. Haas‐Kogan +2 more

Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference

The Lancet Oncology(2023)10.1016/s1470-2045(23)00005-0

N/A

0DataRank · unranked

26 citations

Mei‐Yin C. Polley, Laura Alder, Priscilla K. Brastianos, Carey K. Anders, Hussein A. Tawbi +9 more

Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3524

N/A

0DataRank · unranked

8 citations

Steffen Ventz, Robert Redd, Timothy F. Cloughesy, Brian M. Alexander, Patrick Y. Wen +2 more

Validation of Predictive Analyses for Interim Decisions in Clinical Trials

JCO Precision Oncology(2023)10.1200/po.22.00606

N/A

0DataRank · unranked

4 citations

Steffen Ventz, Andrea Arfè, Brian M. Alexander, Rifaquat Rahman, Patrick Y. Wen +2 more

External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With Glioblastoma

JAMA Oncology(2023)10.1001/jamaoncol.2023.1069

N/A

0DataRank · unranked

3 citations

Steffen Ventz, Lorenzo Trippa, Rifaquat Rahman

Leveraging external data in the design and analysis of clinical trials in neuro-oncology

The Lancet Oncology(2021)10.1016/s1470-2045(21)00488-5

N/A

0DataRank · unranked

85 citations

Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes‐Rivera, Mei‐Yin C. Polley +14 more

Informative censoring in externally controlled clinical trials: a potential source of bias

ESMO Open(2025)10.1016/j.esmoop.2024.104094

N/A

0DataRank · unranked

2 citations

David E. Schwartz, Rita Saha, Patrick Y. Wen, Rifaquat Rahman, Lorenzo Trippa +1 more

The use of external control data for predictions and futility interim analyses in clinical trials

Neuro-Oncology(2021)10.1093/neuonc/noab141

N/A

0DataRank · unranked

45 citations

Leah A. Comment, Bill Louv, Rifaquat Rahman, Patrick Y. Wen, Brian M. Alexander +2 more